<DOC>
	<DOCNO>NCT01630876</DOCNO>
	<brief_summary>This study compare anatomical visual outcome patient idiopathic epiretinal membrane ( ERM ) treat vitrectomy membrane peel without subtenon triamcinolone acetonide injection</brief_summary>
	<brief_title>Outcomes Vitrectomy Combined With Subtenon Triamcinolone Injection Idiopathic Epiretinal Membrane</brief_title>
	<detailed_description />
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1.The participant must idiopathic epiretinal membrane 2.The participant must willing able comply protocol . 1 . The participant idiopathic epiretinal membrane ocular vascular disease Diabetes retinopathy , BRVO , etc . 2 . The participant additional ocular disease irreversibly compromise could likely compromise visual acuity study eye include amblyopia , anterior ischemic optic neuropathy , clinically significant diabetic macular edema , severe non proliferative diabetic retinopathy , proliferative diabetic retinopathy . 3 . The participant intraocular surgery ( include lens replacement surgery ) . 4 . The participant history ( within last six month ) , current ocular periocular infection ( include history ocular herpes zoster simplex ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Epiretinal membrane</keyword>
	<keyword>triamcinolone acetonide</keyword>
</DOC>